Is Johnson & Johnson Now a Has-Been in the COVID Vaccine Market?
Johnson & Johnson (NYSE: JNJ) was once viewed as a leader in the COVID-19 vaccine arena. In this Motley Fool Live video recorded on June 9, Motley Fool contributors Keith Speights and Brian Orelli discuss whether or not J&J is now a has-been in the COVID-19 vaccine market. Keith Speights: Reuters recently reported about another company, Johnson & Johnson.